𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ECM-mediated glioma cell invasion

✍ Scribed by Goldbrunner, Roland H.; Bernstein, Jerald J.; Tonn, Jörg-Christian

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
315 KB
Volume
43
Category
Article
ISSN
1059-910X

No coin nor oath required. For personal study only.

✦ Synopsis

Cell adhesion receptors of the integrin superfamily, CD44, and adhesion receptors of the immunoglobulin superfamily are expressed by high-grade astrocytic tumors of the central nervous system. These receptors are critical for the invasion of these tumors in the nervous system. Glioma cells utilize these receptors to adhere to and migrate along the components of the extracellular matrix, which is uniquely distributed and regulated within the brain and the spinal cord. For this reason, glioma cell invasion into the adjacent brain tissue is dependent on the interaction of glioma cells with the extracellular matrix. The receptor-ECM component interaction is discussed, focusing on the role of cell adhesion molecules of the integrin family and CD44 in glioma cell adhesion and invasion.

📜 SIMILAR VOLUMES

RECK-mediated inhibition of glioma migra
RECK-mediated inhibition of glioma migration and invasion
✍ Tatiana C. Silveira Corrêa; Renato Ramos Massaro; Carla Abdo Brohem; Sebastião R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB

## Abstract __RECK__ is an anti‐tumoral gene whose activity has been associated with its inhibitory effects regulating MMP‐2, MMP‐9, and MT1‐MMP. RECK level decreases as gliobastoma progresses, varying from less invasive grade II gliomas to very invasive human glioblastoma multiforme (GBM). Since R

Effects of ALA-mediated photodynamic the
Effects of ALA-mediated photodynamic therapy on the invasiveness of human glioma cells
✍ Henry Hirschberg; Chung-Ho Sun; Tatiana Krasieva; Steen J. Madsen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Background and Objective: High-grade gliomas are characterized by rapid proliferation, angiogenesis, and invasive growth. Eradication or inhibition of infiltrating glioma cells poses a significant clinical challenge that is unlikely to be solved using conventional treatment regimens consisting of io